Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Treasury Shares (2016 - 2025)

Amicus Therapeutics' Treasury Shares history spans 1 years, with the latest figure at $71000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 41.73% year-over-year to $11.7 million, compared with a TTM value of $11.7 million through Dec 2025, up 41.73%, and an annual FY2025 reading of $11.7 million, up 41.73% over the prior year.
  • Treasury Shares for Q4 2025 was $11.7 million at Amicus Therapeutics, down from $12.2 million in the prior quarter.
  • The five-year high for Treasury Shares was $12.2 million in Q3 2025, with the low at $7390.0 in Q1 2025.
  • Average Treasury Shares over 5 years is $8.4 million, with a median of $9.5 million recorded in 2024.
  • Biggest YoY gain for Treasury Shares was 41.73% in 2025; the steepest drop was 99.92% in 2025.
  • Tracing FOLD's Treasury Shares over 5 years: stood at $7.3 million in 2021, then skyrocketed by 32.37% to $9.7 million in 2022, then rose by 6.32% to $10.3 million in 2023, then fell by 19.88% to $8.3 million in 2024, then skyrocketed by 41.73% to $11.7 million in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Treasury Shares are $71000.0 (Q4 2025), $71000.0 (Q3 2025), and $71000.0 (Q2 2025).